Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1069 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2024-10-28 (statnews.com)
Charles River shipments of research monkeys to Canada spark a probe
Shipments of research monkeys by Charles River Laboratories, one of the largest U.S. clinical research organizations, have recently drawn international scrutiny.
Read more2024-09-05 (globenewswire.com)
CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories’ Directors and Officers for Breach of Fiduciary Duties
SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP (www.johnsonfistel.com), a shareholder rights law firm, announces its continuing...
Read more2024-08-26 (openpr.com)
Investigation announced for Long-Term Investors in shares of Charles River Laboratories International, Inc. (NYSE: CRL) over potential Wrongdoing
Press release - Shareholders Foundation, Inc. - Investigation announced for Long-Term Investors in shares of Charles River Laboratories International, Inc. (NYSE: CRL) over potential Wrongdoing - published on openPR.com
Read more2024-06-21 (forextv.com)
Investigation Alert: Agilon Health, Inc, B. Riley Financial, Charles River Laboratories, and Vertex Energy – Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
SAN DIEGO, June 20, 2024( GLOBE NEWSWIRE)— Johnson Fistel, LLP is conducting a thorough investigation into possible violations of securities laws by specific officers at Agilon Health, Inc.( NYSE: AGL), B. Riley Financial, Inc.( NASDAQ: RILY), Charles River Laboratories International, Inc.( NYSE:
Read more2024-05-29 (globenewswire.com)
Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is conducting a thorough investigation into possible violations of securities laws by...
Read more2024-03-02 (focus.ua)
"Deadly" farm: the US fears a new pandemic because of 30,000 monkeys
They want to sell the animals to universities and pharmaceutical companies to test drugs and study the effects of infectious diseases. Animal rights activists and activists are outraged: the former protect primates, and...
Read more
2023-12-05 (nature.com)
Investigation of monoclonal antibody CSX-1004 for fentanyl overdose
The opioid crisis in the United States is primarily driven by the highly potent synthetic opioid fentanyl leading to >70,000 overdose deaths annually; thus, new therapies for fentanyl overdose are urgently needed. Here, we present the first clinic-ready, fully human monoclonal antibody CSX-1004 with picomolar affinity for fentanyl and related analogs. In mice CSX-1004 reverses fentanyl antinociception and the intractable respiratory depression caused by the ultrapotent opioid carfentanil. Moreover, toxicokinetic evaluation in a repeat-dose rat study and human tissue cross-reactivity study reveals a favorable pharmacokinetic profile of CSX-1004 with no safety-related issues. Using a highly translational non-human primate (NHP) model of respiratory depression, we demonstrate CSX-1004-mediated protection from repeated fentanyl challenges for 3-4 weeks.
Read more2023-06-18 (bakersfield.com)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles ...
NEW YORK, June 17, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL).
Read more2023-06-08 (bakersfield.com)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Charles ...
NEW YORK, June 07, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL).
Read more2023-05-28 (bakersfield.com)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles ...
NEW YORK, May 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL).
Read more2023-05-02 (globenewswire.com)
Investigation Alert: Alico, Charles River Laboratories, Dutch Bros, Catalent: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Alico, Inc. (NASDAQ: ALCO) Johnson Fistel, LLP is investigating potential claims on behalf of Alico, Inc....
Read more
2023-04-16 (globenewswire.com)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
NEW YORK, April 16, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International,...
Read more